For the seventh consecutive year, Baker McKenzie was proud to act as the global editor of the Chambers Life Sciences Practice Guide. Covering 23 jurisdictions, the Firm has provided its characteristic expertise and insight to the annual guide, which offers commentary on a wide range of legal and business issues in major healthcare and life sciences markets.
Chair of the Global Healthcare & Life Sciences Industry Group Vanina Caniza, as well as partners Christian López-Silva, Jane Hobson and Oren Livne, co-authored the global introduction of the guide. The introduction looks at the key topics and strategic imperatives that are impacting this sector, including deal activity, regulatory frameworks, digital transformation, supply chains and IP protection.
The guide provides the latest legal information on challenging the decisions of regulatory bodies; clinical trials; the marketing, manufacturing and distribution of pharmaceuticals and medical devices; pricing; digital healthcare; patents; and developments related to COVID-19.
The reader may welcome the fact that, against a general trend to have increasingly more narrowly defined international guides, the legal content of this publication encompasses two related yet very distinct sectors of life sciences: medicines and medical devices. This makes it the most complete publication, covering all the main aspects of the life cycle of medical products.
The Firm also authored national chapters in three jurisdictions:
- Brazil co-authored by Trench Rossi Watanabe Partners Henrique Frizzo,* Marcela Trigo* and Senior Associates Carla Moraes* and Felipe Zaltman*
- Germany co-authored by Partners Dr. Martin Altschwager and Dr. Thilo Rapple
- Mexico co-authored by Partners Christian Lopez-Silva, Marina Hurtado, Carla Calderón and Jose Hoyos
VIEW PUBLICATION HERE
*Trench Rossi Watanabe and Baker McKenzie have executed a strategic cooperation agreement for consulting on foreign law